Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,980,749,389
+$302,683,940 QoQ
Shares Held
15,674,093
+4.2% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#21
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2020CallValue
$424,926
CallShares
2,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. JNJ ranks #4 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in JNJ
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,980,749,389 | 15,674,093 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,678,065,449 | 15,046,905 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,633,621,062 | 12,725,881 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,524,351,442 | 13,614,235 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,141,089,868 | 14,016,955 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,063,845,234 | 18,474,706 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,766,013,536 | 19,126,079 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,909,642,081 | 17,954,104 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,434,926,055 | 16,659,319 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,256,977,870 | 14,267,513 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,081,847,002 | 13,282,168 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,944,900,703 | 12,487,324 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,275,012,637 | 13,744,639 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,154,756,990 | 13,901,658 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,229,115,779 | 12,618,827 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,190,714,927 | 13,410,351 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,374,498,362 | 13,376,702 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,244,892,112 | 12,666,547 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,142,824,522 | 12,526,010 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,859,490,646 | 11,513,874 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,702,574,383 | 10,334,918 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,694,520,312 | 10,310,437 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $424,926 | 2,700 | Call | Defined | 2021-02-16 | |
| 2020-12-31 | $1,604,637,189 | 10,195,941 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,719,194,324 | 11,547,517 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $401,976 | 2,700 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $393,764 | 2,800 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $1,746,540,073 | 12,419,399 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $367,164 | 2,800 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $1,683,766,891 | 12,840,440 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||